International Advisory Board meeting at the IIMCB
The annual meeting of the International Advisory Board (IAB), held in Warsaw on April 24-26, is a key meeting for the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) due to its strategic importance. Distinguished scientists from around the world participated in a comprehensive program of meetings and deliberations.
This year’s meeting included sessions with the IIMCB Directors, final stage of the competition for Junior Lab Leader positions, and in-depth discussions with members of the PhD Students Council, Postdoctoral Council, and the Senior Researchers Council. During the meeting, the IAB also approved the Director's report for the past year.
An important part of the meeting was the evaluation of Lab Leaders, which featured thematic presentations followed by Q&A sessions. These discussions not only provided invaluable insights but shall also play a decisive role in shaping the future of the respective laboratories.
The meeting was honored by the presence of prominent scientists – members of the IAB, and other international researchers, including:
Anne Spang, University of Basel, Switzerland (Chair of the Board)
Angelo Azzi, Tufts University, USA (Permanent Advisor)
Shelley Berger, University of Pennsylvania, USA
Jo Bury, Flanders Institute for Biotechnology, Belgium
Walter J. Chazin, Vanderbilt University, USA (Advisor)
Susan Gasser, Foundation of the Swiss Institute for Experimental Cancer Research, Switzerland
Reinhard Jahn, Max Planck Institute for Multidisciplinary Sciences, Germany
Artur Jarmołowski, Adam Mickiewicz University, Poland (Advisor)
Jolanta Jura, Jagiellonian University, Poland
Caroline Kisker, University of Würzburg, Germany
Lilianna Solnica-Krezel, Washington University in St. Louis, USA
Juan Valcárcel Juárez, Center for Genomic Regulation, Spain (Secretary)
Eric Westhof, University of Strasbourg, France
Joanna Wysocka, Stanford University, USA
The IIMCB’s International Advisory Board meeting underscored the Institute's commitment to advancing scientific research through global collaboration, and reflected its unique international status as a contributor to the world’s scientific community in life sciences.